Efalizumab-induced inflammatory polyarthritis: What are the implications?

Southern Medical Journal

Volumn 103, Issue 4, 2010, Pages 357-360

  Lyman, Justin ^a   Serebro, Leonard ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Efalizumab; Polyarthritis; Psoriatic arthritis; T cells

Indexed keywords

EFALIZUMAB; METHOTREXATE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; INFLAMMATORY POLYARTHRITIS; LABORATORY TEST; POLYARTHRITIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS;

ANTIBODIES, MONOCLONAL; ARTHRITIS, PSORIATIC; AUTOANTIBODIES; BIOLOGICAL FACTORS; FEMALE; HUMANS; MIDDLE AGED; PEPTIDES, CYCLIC; PSORIASIS;

EID: 77953360524     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181be3559     Document Type: Article

References (15)

1. Rahman P, Elder JT. Genetic epidemiology of psoriasis and psoriatic arthritis. Ann Rheum Dis 2005;64(suppl 2):ii37-ii39; discussion ii40- ii41.
2. Waldburger JM, Firestein GS. Rheumatoid Arthritis: Epidemiology, Pathology, and Pathogenesis, in Klippel JH, Stone JH, Crofford LK, et al (eds): Primer on the Rheumatic Diseases, New York, Springer, 2007, ed 13, pp 123.
3. Ritchlin C, Haas-Smith SA, Hicks D, et al. Patterns of cytokine production in psoriatic synovium. J Rheumatol 1998;25:1544-1552.
4. Leonardi C, Menter A, Hamilton A, et al. Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis. Br J Dermatol 2008;158:1107-1116.
5. Viguier M, Richette P, Aubin F, et al. Onset of psoriatic arthritis in patients treated with efalizumab for moderate to severe psoriasis. Arthritis Rheum 2008;58:1796-1802.
6. Gladman DD, Anhorn KA, Schachter RK, et al. HLA antigens in psoriatic arthritis. J Rheumatol 1986;13:586-592.
7. Korendowych E, Dixey J, Cox B, et al. The influence of the HLA-DRB1 rheumatoid arthritis shared epitope on the clinical characteristics and radiological outcome of psoriatic arthritis. J Rheumatol 2003;30:96-101.
8. van der Helm-van Mil AH, Verpoort KN, Breedveld FC, et al. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anticyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 2006; 54:1117-1121.
9. Harris E, Schur P. Pathogenesis of Rheumatoid Arthritis. UpToDate [database online]. Waltham, MA: UpToDate, Inc.
10. Goronzy JJ, Matteson EL, Fulbright JW, et al. Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis Rheum 2004; 50:43-54.
11. Panayi GS. Immunology of psoriasis and psoriatic arthritis. Baillieres Clin Rheumatol 1994;8:419-427.
12. McQueen FM, Skinner MA, Krissansen GW, et al. Natural killer cell function and expression of beta 7 integrin in psoriatic arthritis. J Rheumatol 1994;21:2266-2273.
13. Nickoloff BJ, Wrone-Smith T. Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol 1999;155:145-158.
14. Ritchlin CT. Pathogenesis of psoriatic arthritis. Curr Opin Rheumatol 2005;17:406-412.
15. List of monoclonal antibodies. [Wikipedia web site]. April 19, 2009. Available at: http://en.wikipedia.org/wiki/List of monoclonal antibodies. Accessed June 30, 2009.